Reformulary Group Inc.

$50,000.00 CAD

≈ 8 months of average Canadian pay
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2018-2019
Agreement period
September 3, 2018 – February 28, 2019
Reference
nrc-cnrc:172-2018-2019-Q4-914180

Published purpose

Cannabis Standard will be an evidence-based medical cannabis formulary based on best available evidence and expert advice. Cannabis Standard includes the formulary with detailed specifications, digital platform that produces the ACMPR-required Medical Document, and registry to capture real-world patient outcomes (quality of life and productivity data).

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions